Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Charlotte, Duchemin"'
Autor:
Maija Radzina, Laura Saule, Edgars Mamis, Ulli Koester, Thomas Elias Cocolios, Elina Pajuste, Marika Kalnina, Kristaps Palskis, Zoe Sawitzki, Zeynep Talip, Mikael Jensen, Charlotte Duchemin, Kirsten Leufgen, Thierry Stora
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 8, Iss 1, Pp 1-16 (2023)
Abstract Background In order to support the ongoing research across Europe to facilitate access to novel radionuclides, the PRISMAP consortium (European medical radionuclides programme) was established to offer the broadest catalog of non-conventiona
Externí odkaz:
https://doaj.org/article/ea5d731c4aaa4b13b7dff743bd86eb1d
Autor:
Jake D. Johnson, Michael Heines, Frank Bruchertseifer, Eric Chevallay, Thomas E. Cocolios, Kristof Dockx, Charlotte Duchemin, Stephan Heinitz, Reinhard Heinke, Sophie Hurier, Laura Lambert, Benji Leenders, Hanna Skliarova, Thierry Stora, Wiktoria Wojtaczka
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract $$^{225}$$ 225 Ac is a radio-isotope that can be linked to biological vector molecules to treat certain distributed cancers using targeted alpha therapy. However, developing $$^{225}$$ 225 Ac-labelled radiopharmaceuticals remains a challenge
Externí odkaz:
https://doaj.org/article/cf82a85391ca40a2992d3cfddaa18a36
Autor:
Edgars Mamis, Charlotte Duchemin, Valentina Berlin, Cyril Bernerd, Mathieu Bovigny, Eric Chevallay, Bernard Crepieux, Vadim Maratovich Gadelshin, Reinhard Heinke, Ronaldo Mendez Hernandez, Jake David Johnson, Patrīcija Kalniņa, Alexandros Koliatos, Laura Lambert, Ralf Erik Rossel, Sebastian Rothe, Julien Thiboud, Felix Weber, Klaus Wendt, Rudolfs Jānis Zabolockis, Elīna Pajuste, Thierry Stora
Publikováno v:
Pharmaceuticals, Vol 17, Iss 3, p 390 (2024)
The radionuclides 43Sc, 44g/mSc, and 47Sc can be produced cost-effectively in sufficient yield for medical research and applications by irradiating natTi and natV target materials with protons. Maximizing the production yield of the therapeutic 47Sc
Externí odkaz:
https://doaj.org/article/875ce47a032c4caa91e58245a23a6741
Autor:
Mehrdad Khoshnevis, Richard Brown, Sara Belluco, Ilyes Zahi, Luca Maciocco, Catherine Bonnefont-Rebeix, Elodie Pillet-Michelland, Jonathan Tranel, Thierry Roger, Christophe Nennig, Patrick Oudoire, Lionel Marcon, Olivier Tillement, Cédric Louis, Hélène Gehan, Manuel Bardiès, Maurizio Mariani, Valeria Muzio, Jean-Philippe Meunier, Charlotte Duchemin, Nathalie Michel, Estelle N’Tsiba, Ferid Haddad, Thierry Buronfosse, Claude Carozzo, Frédérique Ponce
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Glioblastoma is considered the most common malignant primary tumor of central nervous system. In spite of the current standard and multimodal treatment, the prognosis of glioblastoma is poor. For this reason, new therapeutic approaches need to be dev
Externí odkaz:
https://doaj.org/article/8aada16306dc42f0904f1ec20a17adaf
Autor:
Reinhard Heinke, Eric Chevallay, Katerina Chrysalidis, Thomas E. Cocolios, Charlotte Duchemin, Valentin N. Fedosseev, Sophie Hurier, Laura Lambert, Benji Leenders, Bruce A. Marsh, Nicholas P. van der Meulen, Peter Sprung, Thierry Stora, Marianna Tosato, Shane G. Wilkins, Hui Zhang, Zeynep Talip
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Thulium-167 is a promising radionuclide for nuclear medicine applications with potential use for both diagnosis and therapy (“theragnostics”) in disseminated tumor cells and small metastases, due to suitable gamma-line as well as conversion/Auger
Externí odkaz:
https://doaj.org/article/ce0425c15d2642fcbad0027d13a55a82
Autor:
Koen Vermeulen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas, Reinhard Heinke, Laura Lambert, Cyril Bernerd, Andrew R. Burgoyne, Thomas Elias Cocolios, Thierry Stora, Maarten Ooms
Publikováno v:
Pharmaceutics, Vol 14, Iss 12, p 2566 (2022)
Samarium-153 is a promising theranostic radionuclide, but low molar activities (Am) resulting from its current production route render it unsuitable for targeted radionuclide therapy (TRNT). Recent efforts combining neutron activation of 152Sm in the
Externí odkaz:
https://doaj.org/article/bf8a094d04184b509d6e9a3d216dfaea
Autor:
Yisel Martinez Palenzuela, Vincent Barozier, Eric Chevallay, Thomas E. Cocolios, Charlotte Duchemin, Pascal Fernier, Mark Huyse, Laura Lambert, Roberto Lopez, Stefano Marzari, Joao P. Ramos, Thierry Stora, Piet Van Duppen, Alexey Vorozhtsov
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
CERN-MEDICIS is an off-line isotope separator facility for the extraction of radioisotopes from irradiated targets of interest to medical applications. The beamline, between the ion source and the collection chamber, consists of ion extraction and fo
Externí odkaz:
https://doaj.org/article/e25816b10ada4114b1c6f772462bb748
Autor:
Charlotte Duchemin, Joao P. Ramos, Thierry Stora, Essraa Ahmed, Elodie Aubert, Nadia Audouin, Ermanno Barbero, Vincent Barozier, Ana-Paula Bernardes, Philippe Bertreix, Aurore Boscher, Frank Bruchertseifer, Richard Catherall, Eric Chevallay, Pinelopi Christodoulou, Katerina Chrysalidis, Thomas E. Cocolios, Jeremie Comte, Bernard Crepieux, Matthieu Deschamps, Kristof Dockx, Alexandre Dorsival, Valentin N. Fedosseev, Pascal Fernier, Robert Formento-Cavaier, Safouane El Idrissi, Peter Ivanov, Vadim M. Gadelshin, Simone Gilardoni, Jean-Louis Grenard, Ferid Haddad, Reinhard Heinke, Benjamin Juif, Umair Khalid, Moazam Khan, Ulli Köster, Laura Lambert, G. Lilli, Giacomo Lunghi, Bruce A. Marsh, Yisel Martinez Palenzuela, Renata Martins, Stefano Marzari, Nabil Menaa, Nathalie Michel, Maxime Munos, Fabio Pozzi, Francesco Riccardi, Julien Riegert, Nicolas Riggaz, Jean-Yves Rinchet, Sebastian Rothe, Ben Russell, Christelle Saury, Thomas Schneider, Simon Stegemann, Zeynep Talip, Christian Theis, Julien Thiboud, Nicholas P. van der Meulen, Miranda van Stenis, Heinz Vincke, Joachim Vollaire, Nhat-Tan Vuong, Benjamin Webster, Klaus Wendt, Shane G. Wilkins, the CERN-MEDICIS collaboration
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
The CERN-MEDICIS (MEDical Isotopes Collected from ISolde) facility has delivered its first radioactive ion beam at CERN (Switzerland) in December 2017 to support the research and development in nuclear medicine using non-conventional radionuclides. S
Externí odkaz:
https://doaj.org/article/bc36a50ef2ea4effa3c4fabc146732e3
Autor:
Michiel Van de Voorde, Charlotte Duchemin, Reinhard Heinke, Laura Lambert, Eric Chevallay, Thomas Schneider, Miranda Van Stenis, Thomas Elias Cocolios, Thomas Cardinaels, Bernard Ponsard, Maarten Ooms, Thierry Stora, Andrew R. Burgoyne
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Samarium-153 (153Sm) is a highly interesting radionuclide within the field of targeted radionuclide therapy because of its favorable decay characteristics. 153Sm has a half-life of 1.93 d and decays into a stable daughter nuclide (153Eu) whereupon β
Externí odkaz:
https://doaj.org/article/4a450b7f4e2d4e3d8dce6029aafc6dd3
Autor:
Charlotte Duchemin, Thomas E. Cocolios, Kristof Dockx, Gregory J. Farooq-Smith, Olaf Felden, Roberto Formento-Cavaier, Ralf Gebel, Ulli Köster, Bernd Neumaier, Bernhard Scholten, Ingo Spahn, Stefan Spellerberg, Maria E. Stamati, Simon Stegemann, Hannelore Verhoeven
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
This work presents the production cross-sections of Ce, Tb and Dy radionuclides produced by 300 MeV to 1.7 GeV proton-induced spallation reactions in thin tantalum targets as well as the related Thick Target production Yield (TTY) values and ratios.
Externí odkaz:
https://doaj.org/article/043d764e00734d57ad495398e66444e5